Robot-assisted Endoscope Market: By Product Type (Diagnostic and Therapeutic), By Endoscope Type (Flexible Endoscopes, Rigid Endoscopes, and Capsule Endoscopes), By Application (Colonoscopy, Bronchoscopy, Laparoscopy, Gastroscopy, Gynaecology and Urology), By End-use (Hospitals, Ambulatory Surgical Centres and Specialty Clinics), and Geography

Robot-assisted Endoscope Market size was valued at USD 3,892.1 million in 2023 and poised to grow at a CAGR of 11.4% during the forecast years (2024-2030). Modern medical equipment called robot-assisted endoscopes is utilised in less invasive procedures. Using robotic assistance and conventional endoscopy, these devices improve accuracy, control, and surgical outcomes. Surgeons can carry out intricate treatments with better visualisation, less invasiveness, and increased precision. Innovations in robotics and imaging technologies enhance the efficiency and capabilities of robot-assisted endoscopes. For instance, Virtuoso Surgical stated in September 2022 that it will be investing USD 20 million to create endoscopic surgical robots.

Among the surgeries performed are those for endoscopic neurosurgery, uterine fibroids, enlarged prostates, bladder cancer, and the removal of central airway obstructions. Moreover, rising incidences of gastrointestinal disorders, cancers, and other conditions that require endoscopic procedures. However, the high cost of robot-assisted endoscopic devices and procedures prevents widespread use, particularly in underdeveloped nations. Also, stringent approval processes and regulatory requirements can slow down market growth. Whereas, increasing applications in various medical fields such as urology, gynaecology, and gastroenterology can be seen as an opportunity.

Robot-assisted Endoscope Market Key Developments:

• In 2023: Fujifilm increased the range of endoscopic solutions it offers for gastrointestinal therapeutic purposes in January 2023. In the upcoming years, this expansion can aid the business in improving its market placement and income generation.
• In 2022: The ENSEAL X1 Curved Jaw Tissue Sealer, a newly developed laparoscopic bipolar energy device that offers stronger sealing and greater access to more tissue than LigaSureTM Maryland, was introduced on May 24, 2022 by Ethicon, a division of Johnson & Johnson Medical Devices Company. Specialities include bariatric, gynaecological, colorectal, and thoracic surgery can benefit from this technique.
• In 2022: The American Society for Gastrointestinal Endoscopy and Medtronic plc, a leader in healthcare technology worldwide, joined forces on February 22, 2022. With support from Amazon Web Services (AWS), the partnership will enable the business to offer colorectal cancer screening technologies through the Medtronic Health Equity Aid Program to low-income and underprivileged areas across the United States.